An evaluation of circulating activated TAFI in septic DIC: a case series and review of the literature

BACKGROUND: Administration of recombinant human soluble thrombomodulin (rTM) is often used in Japan to treat septic disseminated intravascular coagulation (DIC). Thrombin-activatable fibrinolysis inhibitor (TAFI) is a fibrinolysis inhibitor activated by the thrombin-thrombomodulin complex, however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Totoki, Takaaki, Ito, Takashi, Kakuuchi, Midori, Yashima, Nozomi, Maruyama, Ikuro, Kakihana, Yasuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819972/
https://www.ncbi.nlm.nih.gov/pubmed/35130927
http://dx.doi.org/10.1186/s12959-022-00364-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819972/
https://www.ncbi.nlm.nih.gov/pubmed/35130927
http://dx.doi.org/10.1186/s12959-022-00364-4

Ejemplares similares